Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD1 | P21728 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7574079 | 0.71 | PIK3CD (0.33) | DRD1 | |
| SCHEMBL558046 | 0.67 | NPC1 (0.34) | DRD1 | |
| SCHEMBL558420 | 0.67 | PIK3CD (0.32) | DRD1 | |
| SCHEMBL3991335 | 0.66 | ALDH1A1 (0.34) | — | |
| SCHEMBL4654255 | 0.64 | DRD1 (0.48) | DRD1 | |
| SCHEMBL12292166 | 0.63 | KCNA5 (0.41) | — | |
| SCHEMBL1018686 | 0.62 | TDP1 (0.64) | — | |
| SCHEMBL18257237 | 0.61 | DRD1 (0.39) | DRD1 | |
| SCHEMBL18246159 | 0.61 | DRD1 (0.39) | DRD1 | |
| SCHEMBL19573862 | 0.61 | SMN1; SMN2 (0.40) | DRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130231334-A1 | METHODS OF CONTROLLING NEONICOTINOID RESISTANT APHIDS | SYNGENTA CROP PROTECTION LLC (US) | 2013-09-05 | — | — | US | disclosed |
| EP-2563118-A1 | METHODS OF CONTROLLING NEONICOTINOID RESISTANT APHIDS | Syngenta Participations AG (CH) | 2013-03-06 | — | — | EP | disclosed |
| WO-2011134819-A1 | METHODS OF CONTROLLING NEONICOTINOID RESISTANT APHIDS | SYNGENTA PARTICIPATIONS AG (CH) | 2011-11-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130231334-A1 | METHODS OF CONTROLLING NEONICOTINOID RESISTANT APHIDS | DDT, AGO2, INF2 | DRD1 1314/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.